Learning Objectives:

•Describe the 4 molecular subgroups of medulloblastoma including prognosis and clinical trial stratification
•Describe the 2 molecular subgroups of posterior fossa ependymoma including prognosis
•Describe some of the common genetic alterations seen in low grade glioma and therapeutic implications

 

Session date: 
05/24/2023 - 7:30am to 8:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Eric Thompson, MD